Understanding recidivism and repeat incarceration among young male offenders: a biographical and longitudinal approach. The research focuses on the group of offenders who, as a cohort, annually commit the most crime within Australia. The production of longitudinal qualitative data about individual experiences of secure care, release, and imprisonment, will provide a foundation for empirically driven policies and debates in the area of youth crime and incarceration for each state and territory. A ....Understanding recidivism and repeat incarceration among young male offenders: a biographical and longitudinal approach. The research focuses on the group of offenders who, as a cohort, annually commit the most crime within Australia. The production of longitudinal qualitative data about individual experiences of secure care, release, and imprisonment, will provide a foundation for empirically driven policies and debates in the area of youth crime and incarceration for each state and territory. Accordingly, the community will benefit through the generation of new possibilities for intervening in cycles of persistent offending and repeat custodial sentences. This has major social, cultural and economic implications. Read moreRead less
Near Infrared (IR) Laser Dyes for Latent Fingermark Detection. This project will enable Australian law enforcement agencies to recover latent fingerprints from difficult surfaces through the use of near infrared dyes. The project will allow the recovery of fingerprints from a scene which would otherwise be lost to an investigation. We will provide new fingerprint development techniques and imaging methods to law enforcement agencies, enhancing their ability to identify a perpetrator and thereb ....Near Infrared (IR) Laser Dyes for Latent Fingermark Detection. This project will enable Australian law enforcement agencies to recover latent fingerprints from difficult surfaces through the use of near infrared dyes. The project will allow the recovery of fingerprints from a scene which would otherwise be lost to an investigation. We will provide new fingerprint development techniques and imaging methods to law enforcement agencies, enhancing their ability to identify a perpetrator and thereby reducing crime rates.Read moreRead less
The migration of cancer cells (metastasis) is responsible for most cancer deaths. Central to this is dynamic organisation of the actin cytoskeleton _ an internal structure that provides cell shape and enables movement. We have identified a family of small molecules (called miR-200) that regulates this actin cytoskeleton through specifically downregulating various genes. We are investigating the nature of these genes and their role in cell motility _ an underlying pre-requisite of metastasis.
Can Decision Analytic Modelling Promote Clinical Translation Of Personalised Medicine Markers For Oncology Drugs?
Funder
National Health and Medical Research Council
Funding Amount
$69,893.00
Summary
Personalised medicine is an approach that has great potential to improve healthcare. There has been limited success to date, however, in utilising proposed tests in the clinical. It is proposed that use of mathematical models early in the development of personalised medicine tests will allow early understanding of the value that the test will have for patients and society. Such insight will help build a strong case to undertake the research required before personalised medicine can be more widel ....Personalised medicine is an approach that has great potential to improve healthcare. There has been limited success to date, however, in utilising proposed tests in the clinical. It is proposed that use of mathematical models early in the development of personalised medicine tests will allow early understanding of the value that the test will have for patients and society. Such insight will help build a strong case to undertake the research required before personalised medicine can be more widely used to improve treatment for cancer.Read moreRead less
MICROFABRICATED DEVICES: A SIGNIFICANT ADVANCE FOR THE DETECTION AND MOLECULAR ANALYSES OF CIRCULATING CANCER CELLS?
Funder
National Health and Medical Research Council
Funding Amount
$422,107.00
Summary
Using advanced microfabrication concepts, this project aims to develop a platform technology able to capture tumour cells circulating in the blood of cancer patients. Although present only in extremely small numbers, these cells provide invaluable insights into the pathophysiology of the disease and consequently provide vital diagnostic and prognostic information. Molecular analyses of these cancer cells could ultimately enable the design of improved and personalized cancer treatment.
Suicide Terrorism: The Use of Life as a Weapon. Bali attacks were a powerful reminder that Australians are not immune from terrorism. Suicide terrorism is the most lethal form of terrorism. It constitutes 3 % of all terrorist attacks but accounts for 48 % of all deaths. Australia's involvement in Afghanistan, Iraq and East Timor has made Australia a more likely terrorist target. An informed understanding of suicide terrorism in our region would assist in developing appropriate policies for prote ....Suicide Terrorism: The Use of Life as a Weapon. Bali attacks were a powerful reminder that Australians are not immune from terrorism. Suicide terrorism is the most lethal form of terrorism. It constitutes 3 % of all terrorist attacks but accounts for 48 % of all deaths. Australia's involvement in Afghanistan, Iraq and East Timor has made Australia a more likely terrorist target. An informed understanding of suicide terrorism in our region would assist in developing appropriate policies for protecting Australia from terrorism. The research will also contribute to evaluation of costs and benefits of Australian government policies of democratisation in the region and War on Terror.Read moreRead less
Personalised Medicine Markers Of Anti-EGFR Antibody Therapy In Metastatic Colorectal Cancer: Accelerating Clinical Translation With Collaborative Meta-analyses Based On Individual-participant Data
Funder
National Health and Medical Research Council
Funding Amount
$300,953.00
Summary
When selecting cancer therapy we take into account ‘biomarkers’, biological cancer characteristics that predict treatment success. We will work with an international group, the Advanced Colorectal Cancer Database, to analyse individual patient clinical trial data. We intend to validate biomarkers used to select treatment with cetuximab or panitumumab. Cancer genes called KRAS, NRAS, PTEN, PIK3CA, EREG and BRAF will be examined. Our study will provide best evidence for personalised treatment.
Pushing AR Toward Better Outcomes In Breast And Prostate Cancers
Funder
National Health and Medical Research Council
Funding Amount
$998,754.00
Summary
Breast and prostate cancers kill >6000 Australians each year. These cancers are strikingly similar, both driven by hormone receptors that have ‘gone bad’. Current therapies aim to eradicate the receptors. While often effective, therapeutic resistance is common and results in fatal disease. We aim to develop new, less toxic treatments that switch receptor behaviour from good to bad, without destroying them. This should improve quality of life, while preventing drug resistance and loss of lives ....Breast and prostate cancers kill >6000 Australians each year. These cancers are strikingly similar, both driven by hormone receptors that have ‘gone bad’. Current therapies aim to eradicate the receptors. While often effective, therapeutic resistance is common and results in fatal disease. We aim to develop new, less toxic treatments that switch receptor behaviour from good to bad, without destroying them. This should improve quality of life, while preventing drug resistance and loss of lives.Read moreRead less
Mab Immunotherapies For Myeloid Leukemia Patients With Germline Or Somatic RUNX1 Mutations.
Funder
National Health and Medical Research Council
Funding Amount
$766,995.00
Summary
This proposal presents preliminary evidence and proposes to confirm that 2 cell surface molecules, CD11a (ITGAL) and IL3RA (CD123) are direct (probably repression) targets of RUNX1 in HSCs, and are dysregulated in RUNX1 mutated AML. Monoclonal antibody therapies that target these two surface molecules have already passed different clinical trial phases for different diseases. We plan to show these antibodies are effective in RUNX1 positive AML in preclinical models and then clinical trials.
Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen recepto ....Molecular hallmarks of androgen receptor targeting in prostate cancer. There is a critical need in oncology drug development for better biomarkers of response to prostate cancer therapies, clinically to assist with treatment decision making, and pre-clinically to facilitate translation of emerging agents into clinical practice. Using a unique explant culture model, this project will identify protein and lipid markers that can be used to accurately and reliably assess response to androgen receptor (AR)-targeting therapies in human prostate tumours. The identification and functional assessment of these biomarkers will identify those that can be used as surrogate endpoints in clinical trials, facilitate earlier approval of investigational agents and lead to improved options for therapeutic management of prostate cancer.Read moreRead less